private:newleafventurepartners
|
84602
|
May 30th, 2019 12:00AM
|
New Leaf Venture Partners
|
1.3K
|
25.00
|
Open
|
Venture Capital & Private Equity
|
May 30th, 2019 01:58PM
|
May 30th, 2019 01:58PM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
Open
|
Biopharmaceuticals, Healthcare Technology (Information Convergence), Medical Devices
|
Open
|
7 Times Square, Suite 3502
|
New York
|
NY
|
US
|
10036
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Mar 26th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.2K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Mar 26th, 2018 05:19PM
|
Mar 26th, 2018 05:19PM
|
|
Open
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Feb 17th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.1K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Feb 16th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.1K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Feb 15th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.1K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Feb 14th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.1K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Feb 13th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.1K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Feb 12th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.1K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Feb 11th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.1K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|
private:newleafventurepartners
|
84602
|
Feb 10th, 2018 12:00AM
|
New Leaf Venture Partners
|
1.1K
|
26.00
|
Open
|
Venture Capital & Private Equity
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
|
|
|
|
|
|
|
|
|
|
New Leaf Venture Partners
|
|
Financial Services
|